Arkolith/Insider Trading/ALMR/Form 4

Qiming Corporate GP VI, Ltd.

10% OwnerAlamar Biosciences, Inc. (ALMR) · full profile →Form 4 · filed Apr 22, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
20
12 non-derivative · 8 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 20, 2026Conversion(C)185K——185K
Apr 20, 2026Conversion(C)6.9M——6.9M
Apr 20, 2026Conversion(C)1.6M——1.6M
Apr 20, 2026Conversion(C)1.9M——1.9M
Apr 20, 2026Other(J)185K——0
Apr 20, 2026Other(J)6.9M——0
Apr 20, 2026Other(J)1.6M——0
Apr 20, 2026Other(J)1.9M——0
Apr 20, 2026Other(J)185K——185K
Apr 20, 2026Other(J)6.9M——6.9M
Apr 20, 2026Other(J)1.6M——1.6M
Apr 20, 2026Other(J)1.9M——1.9M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 20, 2026Conversion(C)172K—$00
Apr 20, 2026Conversion(C)6.4M—$00
Apr 20, 2026Conversion(C)154K—$00
Apr 20, 2026Conversion(C)5.7M—$00
Apr 20, 2026Conversion(C)114K—$00
Apr 20, 2026Conversion(C)4.2M—$00
Apr 20, 2026Conversion(C)3.9M—$00
Apr 20, 2026Conversion(C)4.6M—$00

Transaction Codes

C
Conversion of a derivative
J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001231919-26-000392) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML